Xinyue Dai

Title: Inventor Spotlight: Xinyue Dai from Beijing

Introduction: Xinyue Dai is a notable inventor based in Beijing, China, recognized for his innovative contributions in the field of biomedical research and antibody development. As an employee of Bioduro (Beijing) Co., Ltd., he has made strides in creating novel therapeutic solutions aimed at treating various diseases, particularly cancers.

Latest Patents: Among Xinyue Dai's valuable Intellectual Property, he holds a patent for "Antibodies or antigen-binding fragments that bind to OX40." This patent encompasses antibodies that specifically target OX40 and their antigen-binding fragments. These antibodies are crucial for the potential treatment of diseases, such as cancers, thereby offering new hope for therapeutic interventions. The antibodies include a heavy chain variable region featuring one or more CDRs with specific amino acid sequences outlined in SEQ ID NOs: 1-12.

Career Highlights: Xinyue Dai's career is marked by his exemplary work in the biotechnology sector, focusing on the development of targeted therapies. His research and innovation have positioned him as a promising inventor, contributing important knowledge to the realm of antibody technology.

Collaborations: In his career, Xinyue collaborates with talented coworkers such as Jing Li and Guoqian Sun. Together, they synergize their expertise to drive advancements in antibody research, enabling innovative solutions that can impact patient care positively.

Conclusion: Xinyue Dai stands out as an influential inventor in the biomedical industry. His patent on OX40-targeting antibodies reflects his commitment to advancing healthcare solutions. With ongoing collaborations and a focus on impactful research at Bioduro (Beijing) Co., Ltd., he continues to inspire innovations that could change the landscape of disease treatment in the future.